Literature DB >> 11236905

Alterations in arginine metabolic enzymes in trauma.

A C Bernard1, S K Mistry, S M Morris, W E O'Brien, B J Tsuei, M E Maley, L A Shirley, P A Kearney, B R Boulanger, J B Ochoa.   

Abstract

Arginine is the sole substrate for nitric oxide (NO) synthesis by NO synthases (NOS) and promotes the proliferation and maturation of human T-cells. Arginine is also metabolized by the enzyme arginase, producing urea and ornithine, the precursor for polyamine production. We sought to determine the molecular mechanisms regulating arginase and NOS in splenic immune cells after trauma. C3H/HeN mice underwent laparotomy as simulated moderate trauma or anesthesia alone (n = 24 per group). Six, 12, 24, or 48 h later, 6 animals from each group were sacrificed, and splenectomy was performed and plasma collected. Six separate animals had neither surgery nor anesthesia and were sacrificed to provide resting values (t = 0 h). Spleen arginase I and II and iNOS mRNA abundance, arginase I protein expression, and arginase activity were determined. Plasma NO metabolites (nitrite + nitrate) were also measured. Trauma increased spleen arginase I protein expression and activity (P = 0.01) within 12 and for at least 48 h after injury and coincided with up-regulated arginase I mRNA abundance at 24 h. Neither arginase II nor iNOS mRNA abundance in the spleen was significantly increased by trauma at 24 h. Plasma nitrite + nitrate was decreased in animals 48 h post-injury compared to anesthesia controls (P < 0.05). Trauma induces up-regulation of arginase I gene expression in splenic immune cells within 24 h of injury. Arginase II is not significantly up-regulated at that time point. Arginase I, rather than iNOS appears to be the dominant route for arginine metabolism in splenic immune cells 24 h after trauma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11236905     DOI: 10.1097/00024382-200115030-00009

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  7 in total

1.  Major surgery diminishes systemic arginine availability and suppresses nitric oxide response to feeding in patients with early stage breast cancer.

Authors:  Mariëlle P K J Engelen; V Suzanne Klimberg; Arianna Allasia; Nicolaas E P Deutz
Journal:  Clin Nutr       Date:  2017-08-05       Impact factor: 7.324

2.  Systemic arginine depletion after a murine model of surgery or trauma.

Authors:  John P Pribis; Xinmei Zhu; Yoram Vodovotz; Juan B Ochoa
Journal:  JPEN J Parenter Enteral Nutr       Date:  2011-12-16       Impact factor: 4.016

3.  Arginine depletion as a mechanism for the immune privilege of corneal allografts.

Authors:  Hongmei Fu; Adnan Khan; David Coe; Sarah Zaher; Jian-Guo Chai; Pascale Kropf; Ingrid Müller; Daniel F P Larkin; Andrew J T George
Journal:  Eur J Immunol       Date:  2011-09-06       Impact factor: 5.532

4.  Ex-vivo changes in amino acid concentrations from blood stored at room temperature or on ice: implications for arginine and taurine measurements.

Authors:  Joshua S Davis; Christabelle J Darcy; Kim Piera; Yvette R McNeil; Tonia Woodberry; Nicholas M Anstey
Journal:  BMC Clin Pathol       Date:  2009-11-27

5.  Effect of arginase II on L-arginine depletion and cell growth in murine cell lines of renal cell carcinoma.

Authors:  David J Tate; Derek J Vonderhaar; Yupanqui A Caldas; Toye Metoyer; John R Patterson; Diego H Aviles; Arnold H Zea
Journal:  J Hematol Oncol       Date:  2008-09-25       Impact factor: 17.388

6.  Macro- and micronutrient disposition in an ex vivo model of extracorporeal membrane oxygenation.

Authors:  Kristine Estensen; Kiran Shekar; Elissa Robins; Charles McDonald; Adrian G Barnett; John F Fraser
Journal:  Intensive Care Med Exp       Date:  2014-11-22

Review 7.  Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence.

Authors:  Aurora Mirabile; Licia Rivoltini; Elena Daveri; Claudio Vernieri; Roberto Mele; Luca Porcu; Chiara Lazzari; Alessandra Bulotta; Maria Grazia Viganò; Stefano Cascinu; Vanesa Gregorc
Journal:  Cancers (Basel)       Date:  2020-05-04       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.